TheraT® Vectors (Vaccines) Combined With Chemotherapy to Treat HPV16 Head and Neck Cancers

Clinical trial NCT05108870 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05108870
Sponsor: University of Chicago
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Human Papilloma Virus HPV HPV Positive Oropharyngeal Squamous Cell Carcinoma Head and Neck Cancer

Start date: 2022-08-22
Primary completion: 2027-01-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.